Zelluna Immunotherapy Employee Directory

Biotechnology ResearchNorway11-50 Employees

Zelluna Immunotherapy is a company pioneering the development of allogeneic T cell receptor (TCR) guided natural killer (NK) cell immunotherapies for the treatment of solid cancers. The company is developing a portfolio of tumor specific TCRs to guide NK cells with the aim to induce cancer responses that are safe, efficient and durable. 

For more info please visit www.zelluna.com

Find Zelluna Immunotherapy employees' phone numbers or email addresses

Zelluna Immunotherapy Global Highlights

Location
Employees

Europe
25

Minus sign iconPlus sign icon
  • Norway
    20
  • United Kingdom Of Great Britain And Northern Ireland
    3
  • Belgium
    1
  • Germany
    1

Zelluna Immunotherapy's Leadership

  • Stylized image of a person
    N. H.
    Ceo
    Phone icon
  • Stylized image of a person
    A. H.
    Coo & Head Of Business Development
    Phone icon
  • Stylized image of a person
    L. W.
    Chief Scientific Officer
    Phone icon
  • Stylized image of a person
    Ø. F.
    Head Of Clinical Operations
    Phone icon
  • Stylized image of a person
    E. G.
    Head Of Cmc
    Phone icon
  • Stylized image of a person
    E. A.
    Non Executive Director
    Phone icon
  • Stylized image of a person
    G. C. M.
    Finance Director
    Phone icon
  • Stylized image of a person
    M. W.
    Translational Research Lead
    Phone icon

Contact profiles from Zelluna Immunotherapy

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    P. O.
    Cmc Tech Transfer Lead
    Phone icon
    GermanyHessen
    Mar 19, 2025
  • Stylized image of a person
    Z. H.
    Principal Scientist
    Phone icon
    Oct 23, 2025
  • Stylized image of a person
    A. C.
    Senior Scientist
    Phone icon
    NorwayOslo
    Sep 03, 2025
  • Stylized image of a person
    L. M.
    Senior Scientist/ Analytical Development
    Phone icon
    NorwayOslo
    Nov 11, 2025
  • Stylized image of a person
    J. K.
    Senior Scientist
    Phone icon
    Norway
    Jul 14, 2025
  • Stylized image of a person
    M. B.
    Principal Scientist
    Phone icon
    Norway
    Jul 17, 2025
  • Stylized image of a person
    G. M.
    Senior Scientist
    Phone icon
    NorwayOslo
    Apr 03, 2025
  • Stylized image of a person
    M. S.
    Scientific Advisory Board
    Phone icon
    United KingdomEngland
    Oct 23, 2025
  • Stylized image of a person
    P. W.
    Scientist
    Phone icon
    NorwayOslo
    Jul 19, 2025
  • Stylized image of a person
    M. S.
    Scientist
    Phone icon
    NorwayOslo
    Oct 20, 2025

Frequently Asked Questions

What is Zelluna Immunotherapy known for?

Minus sign iconPlus sign icon
Zelluna Immunotherapy was founded in 2016 operates in the Biotechnology Research industry. The company's main headquarters is located in NO. Explore Zelluna Immunotherapy's company overview page for more information.

What is Zelluna Immunotherapy's most common email format?

Minus sign iconPlus sign icon
Zelluna Immunotherapy employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Zelluna Immunotherapy email formats with LeadIQ.

How many employees does Zelluna Immunotherapy have currently?

Minus sign iconPlus sign icon
Zelluna Immunotherapy has approximately 30 employees as of October 2025. These team members are located across 1 continents, including Europe.

Who are Zelluna Immunotherapy's key employees and leadership?

Minus sign iconPlus sign icon

As of October 2025, Zelluna Immunotherapy's key employees include:

  • Ceo: N. H.
  • Coo & Head Of Business Development: A. H.
  • Chief Scientific Officer: L. W.
  • Head Of Clinical Operations: Ø. F.
  • Head Of Cmc: E. G.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.